Related Experiment Video
Updated: Aug 16, 2026
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology
Julie M Myers-Irvin1, Thu-Suong Van Le, Robert H Getzenberg
1Department of Urology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
Abstract:
Analysis of alterations in nuclear structure associated with bladder cancer has revealed specific changes associated with the disease. This includes the identification of six bladder cancer-specific proteins and the successful development of urine-based immunoassays for the detection of two of these biomarkers, BLCA-1 and BLCA-4. The purpose of this study is to examine the functional aspects of BLCA-4 and its potential role in bladder cancer pathobiology. Sequence analysis of BLCA-4 reveals that it is a member of the ETS transcription factor family and that it seems to associate with transcription factors. To examine the effects of this protein, the gene encoding BLCA-4 was stably transfected into human urothelial cells. BLCA-4 expression was confirmed by both PCR and Western blot analysis. BLCA-4 overexpressing clones exhibit a 4.3-fold greater proliferation rate than vector only controls or untransfected cells. Microarray analysis comparing gene expression patterns between overexpressing clones and vector only controls revealed that numerous genes were up-regulated in cells that overexpress BLCA-4. Up-regulated genes included interleukin-1alpha (IL-1alpha), IL-8, and thrombomodulin, and the protein expression of these genes was confirmed by immunoblots. This information has provided a potential model of BLCA-4 action. Overexpression of BLCA-4 seems to increase the growth rate in cells and also causes cells to express a more tumorigenic phenotype.
Insights
Bladder cancer biomarker BLCA-4, an ETS transcription factor, significantly increases cell proliferation and promotes a tumorigenic phenotype by up-regulating key genes like IL-1alpha and IL-8.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bladder cancer is associated with specific nuclear structure alterations.
- Six bladder cancer-specific proteins have been identified.
- Urine-based immunoassays for BLCA-1 and BLCA-4 biomarkers have been developed.
Purpose of the Study:
- To investigate the functional role of BLCA-4 in bladder cancer pathobiology.
- To understand the molecular mechanisms underlying BLCA-4's function.
Main Methods:
- Sequence analysis identified BLCA-4 as an ETS transcription factor.
- Stable transfection of BLCA-4 into human urothelial cells.
- Confirmation of BLCA-4 expression via PCR and Western blot.
- Gene expression profiling using microarray analysis.
- Validation of upregulated gene and protein expression.
Main Results:
- BLCA-4 overexpressing cells showed a 4.3-fold increase in proliferation rate.
- Overexpression of BLCA-4 led to the upregulation of genes including IL-1alpha, IL-8, and thrombomodulin.
- Confirmed protein expression of upregulated genes via immunoblots.
Conclusions:
- BLCA-4 overexpression enhances cell growth and promotes a tumorigenic phenotype.
- BLCA-4 may play a significant role in bladder cancer development and progression.
- Identified a potential molecular model for BLCA-4 action in bladder cancer.